Statistics for Gemina Laboratories Ltd. (id:480 GLAB)

Valuation metrics

Market cap

42.51M

Enterprise value

43.49M

Trailing P/E (ttm)

-10.29

Forward P/E

PEG ratio

Price/Sales (ttm)

Price/Book (mrq)

-19.94

Enterprise Value/Revenue

Enterprise Value/EBITDA

-12.12

Overview

Shares outstanding

74.57M

Float

36.45M

Shares short

1.40K

% Held by insiders

0.44%

% Held by institutions

0.00%

Average volume (10 days)

24.65K

Average volume (90 days)

Price summary

52-Week low

0.28

52-Week high

0.72

52-Week change

44.44%

Beta

0.10

50-Day moving average

0.43

200-Day moving average

0.46

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

January 31th, 2024

Most recent quarter (mrq)

July 31th, 2024

Profitability

Profit margin

0.00%

Operating margin

0.00%

Operational effectiveness

Return on assets

-134.86%

Return on equity

329.09%

Income statement

Revenue (ttm)

0.00

Revenue per share (ttm)

0.00

Quarterly revenue growth (yoy)

Gross profit (ttm)

0.00

EBITDA

-3,588,245.00

Net income to common (ttm)

-3,723,630.00

Diluted EPS (ttm)

-0.04

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

206.84K

Total cash per share (mrq)

0.00

Total debt (mrq)

1.19M

Total Debt/Equity (mrq)

-0.45

Current ratio (mrq)

9.20%

Book value per share (mrq)

-0.04

Cash flow

Cash flow statement

-1,353,877.00

Levered free cash flow (LFCF)

-140,510.00